SimConverse
SimConverse is an Australian AI company that provides proprietary, domain-specific generative AI simulation platforms for healthcare communication training. It serves universities, medical, nursing, pharmacy, and allied health schools, plus healthcare systems globally, with multimodal avatar-based training and rubric-grounded assessment.
- Company typePrivate
- Founded2021
- HeadquartersSydney, Australia
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What SimConverse does
SimConverse (legally Dymaxion Technologies Pty Ltd, ACN 645 573 066) is an Australian healthcare-education technology company founded in 2021 and headquartered in Sydney, with regional offices in Austin, TX (North America) and London (EMEA). The company builds proprietary, single-purpose AI models trained specifically for healthcare dialog simulation, explicitly not based on general-purpose large language models such as GPT-4 or Gemini. Its platform delivers photorealistic AI-simulated patients that engage learners in real-time spoken conversation, assess clinical reasoning and actions, and provide rubric-based, natural-language feedback on communication skills, documentation quality, and professional competence.
The product is structured as an integrated five-module platform: Engage (learner interaction with AI avatars), Control (authoring of characters, rubrics, and activities), Deploy (cohort management and automation), Measure (institution-to-rubric analytics and accreditation exports), and Integrate (SSO, LTI 1.3 LMS integration, curriculum mapping, and transition services). SimConverse is sold on a quote-based annual subscription basis through an enterprise field-sales motion to universities, medical, nursing, pharmacy, optometry, and surgery schools, allied health programs, NHS trusts, and government health authorities. Pricing is not publicly disclosed. The company maintains SOC 2 Type 2, ISO 27001, HIPAA, FERPA, UK GDPR, and Australian Privacy Act compliance, with customer data hosted in AWS regions within the customer's home jurisdiction.
The company has raised 1.5 million AUD (~US$989K) in seed funding in March 2023, led by Folklore Ventures with Artesian VC and Boab AI participating. As of the latest available data, the company operates with 11-50 employees and serves more than 27 named institutional customers across the US, UK, Australia, and New Zealand, including the University of Liverpool, King's College London, University of Sydney, Villanova University, University of Auckland, Aston University, University of Nottingham, NHS England, NHS Lothian, and Queensland Government. Reported validation includes an equivalence-to-human-actors RCT at p=0.86, a 1.65 SD improvement in communication skills at Villanova, and 12,000+ learners reached across a 2024 multi-site effectiveness study.
SimConverse firmographics
Firmographics- Name
- SimConverse
- Legal name
- Dymaxion Technologies Pty Ltd
- Website
- https://simconverse.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- SimConverse is an Australian AI company that provides proprietary, domain-specific generative AI simulation platforms for healthcare communication training. It serves universities, medical, nursing, pharmacy, and allied health schools, plus healthcare systems globally, with multimodal avatar-based training and rubric-grounded assessment.
- Ownership category
- akta.pro rank
SimConverse industry classification
Industry- Product category
- Healthcare Communication Simulation
- NAICS
- Professional and Management Development Training (61143), Computer Training (611420)
- SIC
- Services-Prepackaged Software (7372), Services-Health Services (8000)
- akta.pro primary industry
- Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction) (EDAFAJAC)
- akta.pro secondary industry
- Conversational AI Platforms (chat/voice bots, orchestration) (HDAAAFAC)
Keywords
Where SimConverse is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices3 records
Markets served
SimConverse business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- SaaS Platform Subscription: SimConverse operates as a SaaS platform providing AI-powered healthcare communication training to educational institutions. The platform is sold to universities, healthcare schools, and medical institutions with features including curriculum mapping, accreditation support, and enterprise integration. Pricing is quote-based, indicating enterprise licensing rather than self-serve pricing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise institutional licensing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
SimConverse product offering
Product offeringCore offering
SimConverse provides a unified AI-powered healthcare communication training platform that uses proprietary, purpose-built AI models (not general-purpose LLMs) to simulate patient conversations for healthcare students and professionals. The platform enables real-time spoken interactions with photorealistic AI avatars, automated rubric-based assessment of communication, clinical reasoning, and documentation, and delivers analytics, cohort management, curriculum mapping, and accreditation support to universities, medical schools, and healthcare systems.
Product overview
SimConverse is a unified AI-powered healthcare communication training platform built as an integrated system of five interconnected modules. The platform uses proprietary purpose-built AI models (not general-purpose LLMs) to simulate medical communication scenarios for training healthcare professionals. The five modules—Engage (AI conversation simulation with photorealistic avatars), Control (rubric and activity authoring), Deploy (cohort management and automation), Measure (analytics and rubric heatmaps), and Integrate (curriculum mapping and compliance)—work together as a single platform replacing multiple training tools. The platform assesses spoken communication, clinical reasoning/actions, and written documentation through a multi-modal approach grounded in evidence-based stage-based learning theory.
Differentiator
Problem solved
Functional benefit
Products and services
- SimConverse Engage (Module 1.0)
Quantifiable outcome
- p = 0.86 equivalence to human actors (Aston University, Optometry RCT, 2025)
- +9 more outcomes
Companies that use SimConverse
Customer profileNamed customers28 records
Segments4 records
Ideal customer profiles2 records
SimConverse technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability8 records
Feature5 records
SimConverse partnerships and signals
Strategic signalScale indicators12 records
Recent moves6 records
Expansion highlights6 records
SimConverse competitors and assessment
Company assessmentDirect peers
- SimX: VR medical simulation platform for clinicians and medical students across emergency, surgical, and inpatient scenarios. Targets similar healthcare education buyers with comparable simulation procurement budgets.
- Body Interact: Virtual patient simulator used by medical and nursing schools for clinical reasoning and communication practice. Same buyer profile (medical/nursing schools), similar use cases in clinical communication skills development.
- Mursion: AI-driven human-avatar simulation platform for soft-skills and communication training, with dedicated healthcare vertical. Strongest direct competitor on AI-simulated patient conversations for healthcare professionals and students.
- Health Scholars: VR-based clinical training platform focused on nursing, emergency, and resuscitation scenarios at hospitals and nursing schools. Comparable product/market overlap in immersive clinical simulation for healthcare professionals.
- FundamentalVR: Haptic VR surgical and clinical simulation platform used in medical education. Comparable buyer base (medical schools, teaching hospitals) focused on experiential clinical skills training.
- UbiSim: VR-based nursing simulation platform serving nursing schools and hospitals. Direct competitor in the nursing-education segment with overlapping procurement cycles and learner cohorts.
- Oxford Medical Simulation: Direct competitor offering VR-based healthcare simulation for nursing and medical training. Closely aligned product/category, sharing healthcare education buyers and competing for the same institutional RFPs.
Broad incumbents
- CAE Healthcare: Established large-scale healthcare simulation provider with broad portfolio across patient simulation, ultrasound training, and learning ecosystems. Competes indirectly through institutional simulation budgets and procurement.
- Laerdal Medical (SimCapture): Global incumbent in healthcare simulation, including standardized patient programs and SimCapture simulation management. Significantly larger with broader portfolio (manikins, simulation centers) that complement or compete with SimConverse's software-only approach.
Emerging players
- Kognito: Conversational AI platform for behavioral health and communication skills training in health professions. Overlaps with SimConverse's mental-health patient simulation and communication practice use cases (e.g., PHQ-A screening).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
SimConverse social profiles
Digital presenceSimConverse compliance and trust
Trust signalCompliance6 records
SimConverse financial estimates
Financial estimateRevenue estimate
Valuation estimate
SimConverse leadership team
Management profileNumber of profiles
SimConverse funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SimConverse M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SimConverse
What does SimConverse do?
SimConverse provides a unified AI-powered healthcare communication training platform that uses proprietary, purpose-built AI models (not general-purpose LLMs) to simulate patient conversations for healthcare students and professionals. The platform enables real-time spoken interactions with photorealistic AI avatars, automated rubric-based assessment of communication, clinical reasoning, and documentation, and delivers analytics, cohort management, curriculum mapping, and accreditation support to universities, medical schools, and healthcare systems.
Is SimConverse a public or private company?
SimConverse is a private company. It is classified as venture growth investor backed and is currently operating.
When was SimConverse founded?
SimConverse was founded in 2021. It employs 11 to 50 people.
Where is SimConverse based?
SimConverse is headquartered in Sydney, Australia, in the Oceania region.
How does SimConverse make money?
One revenue line is on record: saaS Platform Subscription.
Who are SimConverse's main competitors?
Direct peers on record are SimX, Body Interact, Mursion, Health Scholars, FundamentalVR, UbiSim and Oxford Medical Simulation. Broad incumbents are CAE Healthcare and Laerdal Medical (SimCapture). Kognito is listed as an emerging player.
Does SimConverse have an API?
No public API is recorded for SimConverse.
What industry is SimConverse in?
SimConverse's product category is Healthcare Communication Simulation. Its primary akta.pro industry code is EDAFAJAC, Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction), with a secondary code of HDAAAFAC, Conversational AI Platforms (chat/voice bots, orchestration). Its NAICS code is 61143 and its SIC code is 7372.